دورية أكاديمية
Effects of technology-enabled blood pressure monitoring in primary care: A quasi-experimental trial.
| العنوان: | Effects of technology-enabled blood pressure monitoring in primary care: A quasi-experimental trial. |
|---|---|
| المؤلفون: | Teo VH; National Healthcare Group Polyclinics, Singapore., Teo SH; National Healthcare Group Polyclinics, Singapore., Burkill SM; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Wang Y; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Chew EA; National Healthcare Group Polyclinics, Singapore., Ng DW; National Healthcare Group Polyclinics, Singapore., Tang WE; National Healthcare Group Polyclinics, Singapore., Koh GC; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.; Ministry of Health Office for Healthcare Transformation, Singapore. |
| المصدر: | Journal of telemedicine and telecare [J Telemed Telecare] 2024 Jan; Vol. 30 (1), pp. 121-130. Date of Electronic Publication: 2021 Jul 30. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sage Country of Publication: England NLM ID: 9506702 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1109 (Electronic) Linking ISSN: 1357633X NLM ISO Abbreviation: J Telemed Telecare Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Dec. 2012- : London : Sage Original Publication: London : Published and distributed by Royal Society of Medicine Press, c1995- |
| مواضيع طبية MeSH: | Telemedicine*/methods , Hypertension*/diagnosis , Hypertension*/therapy, Humans ; Blood Pressure ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Cohort Studies ; Primary Health Care ; Cost-Benefit Analysis |
| مستخلص: | Introduction: Technology to enhance hypertension management is increasingly used in primary care; however, it has not been evaluated in an Asian primary care setting. We aimed to understand the clinical impact and cost-effectiveness of a technology-enabled home blood pressure monitor when deployed in primary care, and patients' perspectives about the technology. Methods: A quasi-experimental cohort study was conducted in a polyclinic in Singapore. In total, 120 patients with hypertension were assigned to the telemonitoring intervention group. Patients received a home blood pressure device connected to the clinical care team's dashboard through a mobile gateway. Tele-consultations and nurse-led tele-support were carried out using established clinical protocols. In total, 120 patients assigned to the control group continued to receive usual care in the polyclinic. Clinical outcomes, cost-effectiveness, and patient satisfaction were measured 6 months after recruitment. Results: In total, 217 patients completed 6 months of follow-up. Telemonitoring intervention patients had significantly increased odds of having controlled blood pressure by a factor of 2.69 ( p = 0.01), with the greatest improvement in those whose blood pressure was uncontrolled at baseline ( p < 0.05). The incremental cost-effectiveness ratios for all patients was S$23,935.14/quality-adjusted life year (<1 gross domestic product per capita), which was very cost-effective based on World Health Organization cost-effectiveness thresholds. There was greater satisfaction in telemonitoring intervention group relating to the convenience of recording and sharing blood pressure measurements with the health care team, consultation advice received, understanding by the health care team of their condition, and were more motivated to monitor their blood pressure. Discussion: Telemonitoring with tele-consultation improved blood pressure control and was more cost-effective than usual care. Patients receiving telemonitoring intervention were also more motivated and satisfied with their care. Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
| References: | Blood Press. 2011 Apr;20(2):117-25. (PMID: 21105759) Arch Intern Med. 2011 Jul 11;171(13):1173-80. (PMID: 21747013) JAMA. 1996 May 22-29;275(20):1571-6. (PMID: 8622248) J Hypertens. 2013 Mar;31(3):455-67; discussion 467-8. (PMID: 23299557) Pharmacoeconomics. 2014 May;32(5):495-507. (PMID: 24519603) J Hum Hypertens. 2017 Jul;31(7):427-437. (PMID: 28332506) Can Fam Physician. 2018 Nov;64(11):832-840. (PMID: 30429181) Hypertension. 2014 Oct;64(4):891-6. (PMID: 25024284) BMJ. 2021 Jan 19;372:m4858. (PMID: 33468518) Blood Press Monit. 2006 Oct;11(5):257-67. (PMID: 16932035) JAMA Netw Open. 2018 Sep 7;1(5):e181617. (PMID: 30646139) BMJ Open. 2012 Nov 28;2(6):. (PMID: 23192242) Lancet. 2018 Mar 10;391(10124):949-959. (PMID: 29499873) Ann Intern Med. 2009 Nov 17;151(10):687-95. (PMID: 19920269) BMC Fam Pract. 2014 Mar 07;15:43. (PMID: 24606887) Lancet. 2006 May 27;367(9524):1747-57. (PMID: 16731270) Am J Manag Care. 2011 Apr;17(4):e96-103. (PMID: 21774100) |
| فهرسة مساهمة: | Keywords: Telemedicine; blood pressure monitoring; cost-effectiveness; hypertension; primary health care |
| المشرفين على المادة: | 0 (Antihypertensive Agents) |
| تواريخ الأحداث: | Date Created: 20210730 Date Completed: 20231225 Latest Revision: 20231225 |
| رمز التحديث: | 20231225 |
| مُعرف محوري في PubMed: | PMC10748448 |
| DOI: | 10.1177/1357633X211031780 |
| PMID: | 34328375 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1758-1109 |
|---|---|
| DOI: | 10.1177/1357633X211031780 |